General Information of the Compound
| Compound ID |
CP0857654
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(5R*)-N5-(2-(4-Bromophenyl)ethyl)-(6R*)-N6-(4-pyrrolidino-butyl)-(4S*,7R*)-[4,7-ethenylene-spiro[2.4]heptane]-5,6-dicarboxamide, formate salt
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C28H38BrN3O4
|
||||||||||||||||||
| Molecular Weight |
560.533
|
||||||||||||||||||
| Canonical SMILES |
O=C(NCCCCN1CCCC1)[C@H]1[C@H](C(=O)NCCc2ccc(Br)cc2)[C@@H]2C=C[C@H]1C21CC1.O=CO
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C27H36BrN3O2.CH2O2/c28-20-7-5-19(6-8-20)11-15-30-26(33)24-22-10-9-21(27(22)12-13-27)23(24)25(32)29-14-1-2-16-31-17-3-4-18-31;2-1-3/h5-10,21-24H,1-4,11-18H2,(H,29,32)(H,30,33);1H,(H,2,3)/t21-,22+,23-,24-;/m1./s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
BNFZKZYDJKVHGM-NVGWGOIQSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00605, FML2_HUMAN
Protein ID: PT02590, N-formyl peptide receptor 2